Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
70 bpm on day 28
2014-000269-27Phase 4Active
- Sponsor
- Deutsche Stiftung für Chronisch Kranke
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ivabradine in chronic heart failure (CHF) (2 arms), sponsored by Deutsche Stiftung für Chronisch Kranke. Primary endpoint: Resting heart rate ≤ 70 bpm at T1. Started Jun 2014; status: active.
02
Drugs
ivabradine
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2014-000269-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000269-27.